Skip to content

DENTSPLY SIRONA XRAY Return on equity

Return on equity at other companies

Align Technology logo
Align TechnologyALGN
10.8%0.0pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
2.2%+1.1pp
Solventum logo
SolventumSOLV
34.8%+24.1pp
Henry Schein logo
Henry ScheinHSIC
12%+0.2pp
Globus Medical logo
Globus MedicalGMED
13.3%+8.7pp
Novanta logo
NovantaNOVT
5.2%-4.6pp

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$190.0M-52.3%
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%
Free cash flow-$12.0M0.0%

Valuation

See full
Market cap$2.04B-22.1%
Enterprise value$4.18B-10.8%
P/S0.6×-0.2×

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Calculated from DENTSPLY SIRONA’s reported figures.

Based on trailing twelve months.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's return on equity?
DENTSPLY SIRONA (XRAY) reported return on equity of -37.7% in Q1 2026.
How has DENTSPLY SIRONA's return on equity changed year-over-year?
DENTSPLY SIRONA's return on equity decreased by 9.5% year-over-year, from -34.5% to -37.7%.
What is the long-term trend for DENTSPLY SIRONA's return on equity?
Over 4 years (2020 to 2025), DENTSPLY SIRONA's return on equity has grown at a 123.7% compound annual growth rate (CAGR), from -1.5% to -36.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.